| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 21, 2019 | 279.50 | 295.00 | 279.00 | 290.00 | 62,192 |
| May 20, 2019 | 296.25 | 301.75 | 272.50 | 280.00 | 154,085 |
| May 17, 2019 | 324.80 | 325.00 | 296.51 | 302.50 | 89,520 |
| May 16, 2019 | 288.00 | 320.00 | 288.00 | 317.00 | 253,378 |
| May 15, 2019 | 269.21 | 295.00 | 269.21 | 290.00 | 117,494 |
| Name | ReNeuron Group | Epic | RENE |
|---|---|---|---|
| ISIN | GB00BF5G6K95 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 3,000 | Prev Close | 290.00 |
| Shares in Issue (m) | 31.80 | Market Cap (£m) | 92.22 |
| PE Ratio | -5.21 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -55.70 | EPS Growth (%) | -11,040.00 |
| PEG | 0.00 | DPS Growth (%) | n/a |
| ROCE | -57.19 | Net Gearing | -51.53 |
| Quick Ratio | 7.01 | Current Ratio | 7.01 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 09 Nov | Stifel | Buy | 285.00 | 13.00 | 13.00 | Reiterates |
| 29 Jun | N+1 Singer | Buy | 285.00 | - | - | Reiterates |
| 27 Apr | N+1 Singer | Buy | 285.00 | 9.00 | 9.00 | Reiterates |
| 04 Apr | Stifel | Buy | 285.00 | 15.00 | 15.00 | Reiterates |
| 04 Jan | N+1 Singer | Buy | 285.00 | 9.00 | 9.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 18 Apr 2019 | Prof Sir Chris Evans | Buy | 10,000 @ 228.70p | £22,870.00 |
| 11 Apr 2019 | John Berriman | Buy | 80,000 @ 225.00p | £180,000.00 |
| 11 Apr 2019 | Simon Cartmell | Buy | 7,758 @ 225.55p | £17,498.17 |
| 11 Apr 2019 | Prof Sir Chris Evans | Buy | 4,500 @ 221.50p | £9,967.50 |
| 11 Apr 2019 | Dr Mike Owen | Buy | 4,237 @ 236.00p | £9,999.32 |
